Medical significance of peroxisome proliferator-activated receptors.
about
Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR)Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligandsDual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons.Receptor Ck-dependent signaling regulates hTERT gene transcription.Mortality from ischemic heart disease and diabetes mellitus (type 2) in four U.S. wheat-producing states: a hypothesis-generating studyActivation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cellsNitration of PPARgamma inhibits ligand-dependent translocation into the nucleus in a macrophage-like cell line, RAW 264PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4Role of peroxisome proliferator-activated receptor-gamma (PPARgamma) during liver regeneration in ratsPeroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitroA pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis.Molecular biology of Barrett's adenocarcinoma.Pharmacological peroxisome proliferator-activated receptorgamma ligands: emerging clinical indications beyond diabetes.Gene expression of transporters and phase I/II metabolic enzymes in murine small intestine during fasting.Transcriptome alteration in the diabetic heart by rosiglitazone: implications for cardiovascular mortality.Rosiglitazone sensitizes hepatocellular carcinoma cell lines to 5-fluorouracil antitumor activity through activation of the PPARgamma signaling pathwaySkin innate immune system in psoriasis: friend or foe?Regulation of cytochrome P450 (CYP) genes by nuclear receptors.Rice bran oil and gamma-oryzanol in the treatment of hyperlipoproteinaemias and other conditions.Atherogenic dyslipidemia and diabetes mellitus: what's new in the management arena?Ursodeoxycholic acid ameliorates fructose-induced metabolic syndrome in rats.Effects of the PPARα Agonist and Widely Used Antihyperlipidemic Drug Gemfibrozil on Hepatic Toxicity and Lipid Metabolism.Clustering of metabolic abnormalities in obese individuals: the role of genetic factors.Adipocyte metabolism and the metabolic syndrome.Regulation of fatty acid oxidation in mouse cumulus-oocyte complexes during maturation and modulation by PPAR agonists.PPAR-γ regulates carnitine homeostasis and mitochondrial function in a lamb model of increased pulmonary blood flowRole of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in miceEffect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients.Peroxisome proliferator-activated receptor gamma agonists: potential use for treating chronic inflammatory diseases.Molecular Implications of the PPARs in the Diabetic Eye.Evolution of peroxisome proliferator-activated receptor agonists.Tesaglitazar, as add-on therapy to sulphonylurea, dose-dependently improves glucose and lipid abnormalities in patients with type 2 diabetes.Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production.Peroxisome proliferator-activated receptor (PPAR) γ and PPARα agonists modulate mitochondrial fusion-fission dynamics: relevance to reactive oxygen species (ROS)-related neurodegenerative disorders?Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes.Genetic-dependency of peroxisomal cell functions - emerging aspects.Effect of pioglitazone on excitotoxic neuronal damage in the mouse hippocampusActivation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism.Colon cancer: genomics and apoptotic events.5, 8, 11, 14-eicosatetraynoic acid suppresses CCL2/MCP-1 expression in IFN-γ-stimulated astrocytes by increasing MAPK phosphatase-1 mRNA stability.
P2860
Q24793496-A8166AE4-E6BA-4216-B44A-9E6FCAA03E0BQ24810709-FCF7CE31-C57E-4F1C-BA4D-02863D61AE6DQ24816834-D4BB682F-27A5-40FF-AF79-3C0113776EFBQ25255748-FAE8E2E6-9CEE-47DC-AA52-CF09E6F91690Q25257294-0A6F23B2-1F2C-4026-AB19-6CD261651565Q28214426-9A768B9B-11DC-4097-99A5-E2931E2DDD59Q28513008-3509D820-3949-434C-80DE-130E574815AAQ28574163-2171AD0A-A5C7-4866-9139-45C72C2E8E27Q28577013-DD9BD4D0-4D3B-4581-9C9E-69D51940E71FQ28577768-731260E3-3414-4F26-BCAC-88C27F0EA591Q30306955-3A5BFEB6-5A50-4977-B51C-61B2D6858D81Q30327935-EB59D5B3-BEF4-4B8A-A7D8-0F89811ED59AQ30977623-944D9ACD-04A3-418B-B6E4-AC359D5B2F4AQ33293463-ACCFFA65-B048-45D9-820B-61CC148390DDQ33354126-64798753-CB7F-4BB0-8F76-5D231A931F20Q33554975-2C63D420-1045-48E1-AB49-222F4FEF1B49Q33764350-1E96E68F-B13C-4C1E-A7CA-C5A212830393Q33882753-A9005237-66AF-4187-A3AB-B095FB3072EEQ33951461-88B846EA-E352-4D8B-8F16-682E083324B6Q34139042-80671655-E601-4876-B7F3-4C17459ED5DBQ34155978-A6B01213-8029-435F-A342-3048A0F8D356Q34189111-FAC779EF-9CC5-4A8B-A38C-C7543F09FF37Q34235218-7A5B6EFF-D0EC-4FBB-837C-6CE9ADAECD58Q34285949-B564B44E-CBD7-47B1-A62C-A1A93783059FQ34403000-88C59EDF-4076-42DD-A9C8-C0BF70C48EF5Q34409704-4F4A0957-B082-4861-989A-1699F8772DCAQ34442164-0F080872-793D-4788-9ADD-011873BF5626Q34557349-53F2F464-BC82-4CFA-A0B5-085DFF34BA52Q34580424-21EDC79C-27FC-4EE4-A99F-012BD3E9E453Q34594935-C49F7447-9E5E-42C5-9ABA-9E1C8DF54A37Q34630829-51A694DD-D28A-476D-A906-E0C676D5EE3FQ34695851-01799C77-4C34-4A89-B6AB-1F917185A26BQ34713346-DE2881D5-C040-44A1-A3E1-B6A8E53346A1Q34723198-454B2D59-688C-423B-A4C6-8AA0962B3035Q35139747-8384EA01-D706-4812-8B9B-289FDF00108BQ35574139-183D0F61-29D9-4F10-8916-C5C11B816B04Q35597512-7F18C263-924A-4F69-B16B-2C547CAF8FD7Q35750111-54A30348-0C90-4B33-AAF0-DB5F14958D93Q35837213-6170BD25-0294-48A2-8F4E-5DA8F08E8F4DQ35842324-69C9135E-7E5A-4C2A-BF98-0E40FF0BF6D2
P2860
Medical significance of peroxisome proliferator-activated receptors.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Medical significance of peroxisome proliferator-activated receptors.
@ast
Medical significance of peroxisome proliferator-activated receptors.
@en
Medical significance of peroxisome proliferator-activated receptors.
@nl
type
label
Medical significance of peroxisome proliferator-activated receptors.
@ast
Medical significance of peroxisome proliferator-activated receptors.
@en
Medical significance of peroxisome proliferator-activated receptors.
@nl
prefLabel
Medical significance of peroxisome proliferator-activated receptors.
@ast
Medical significance of peroxisome proliferator-activated receptors.
@en
Medical significance of peroxisome proliferator-activated receptors.
@nl
P1433
P1476
Medical significance of peroxisome proliferator-activated receptors
@en
P2093
N Latruffe
P304
P356
10.1016/S0140-6736(98)10364-1
P407
P50
P577
1999-07-01T00:00:00Z